Reck M, von Pawel J, Zatloukal P, et al. Overall survival with cisplatin -gemcitabine and bevacizumab or placebo as first- line therapy for nonsquamous non -small -cell lung cancer: results from a randomized phase III trial (AVAiL). Ann Oncol 2010; 21: 1804-09.